2017
DOI: 10.1097/mpg.0000000000001542
|View full text |Cite
|
Sign up to set email alerts
|

Fecal Calprotectin and Eosinophil‐derived Neurotoxin in Healthy Children Between 0 and 12 Years

Abstract: By using an improved analytical method, we have confirmed that young healthy children have higher fCP concentrations than healthy adults. We, for the first time, report reference values for fEDN concentrations in a pediatric population. The proposed nomograms and reference values for fCP and fEDN are aimed at facilitating the applicability of biomarkers for both neutrophil- and eosinophil-mediated intestinal inflammation in children in clinical practice.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
44
1
3

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(52 citation statements)
references
References 26 publications
4
44
1
3
Order By: Relevance
“…In our study, the mean EDN concentration in stool was significantly higher in the study group than in controls ( p <0.05), sensitivity reached 74.1%, specificity 80% with cut off value 884.45 ng/mL. The before mentioned study, by Roca et al, estimated the 95th percentile for EDN upon 7.4 mg/kg in infants, which remains in the agreement with our results [ 22 ].…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…In our study, the mean EDN concentration in stool was significantly higher in the study group than in controls ( p <0.05), sensitivity reached 74.1%, specificity 80% with cut off value 884.45 ng/mL. The before mentioned study, by Roca et al, estimated the 95th percentile for EDN upon 7.4 mg/kg in infants, which remains in the agreement with our results [ 22 ].…”
Section: Discussionsupporting
confidence: 92%
“…Ezri et al indicated that fCal values are age-dependent and estimated cut-off levels upon <350 µg/g in the first year of life [ 21 ]. A recent study has presented the normogram for fCal concentration, in which the 95th percentile being 910.3 mg/kg for 0–12 months of age [ 22 ]. In our study, the median fCal value was 331.7 µg/g, 74–751 µg/g in 25 controls below 1 year of age, similar to Ezir et al results and significantly lower than the Roca et al study.…”
Section: Discussionmentioning
confidence: 99%
“…In healthy adult patients, FC concentrations < 50 µg/g faeces is considered to be normal, concentrations between 50 and 100 µg/g are treated as borderline while concentrations > 100 µg/g need more precise intervention and deeper clinical workup ( 13 ). Importantly, FC concentrations have been shown to vary with age, the highest concentrations reported in new-borns ( 14 17 ).…”
Section: Introductionmentioning
confidence: 99%
“…Oord e Hornung (2014) sugeriram 3 valores de ponto de corte para avaliar CLP em crianças saudáveis, baseados nos percentis 97,5%: 538 mg/kg (1 a 6 meses), 214 mg/kg (6 meses a 3 anos) e 75 mg/kg (3 a 4 anos). Roca et al (2017) também encontraram valores elevados de CLP nos primeiros anos de vida de crianças saudáveis (17,3 mg/kg a 2681,7 mg/kg ) e sugeriram valores de referência para a faixa pediátrica, considerando o percentil 95% para cada faixa etária: 910,3 mg/kg (0 a 12 meses), 285,9 mg/kg (1 a 4 anos) e 54,4 mg/kg ( 4 a 12 anos). No presente estudo, também foram observados valores maiores de CLP nos menores de 4 anos em relação às crianças saudáveis, porém sem diferença significante em relação aos maiores de 4 anos (p = 0,30), com médias e medianas superiores às descritas na literatura.…”
Section: Discussionunclassified
“…Apesar da sugestão de alguns autores em relação aos pontos de corte em diferentes grupos etários, os achados são muito variáveis entre os trabalhos, ainda não permitindo o estabelecimento de um ponto de corte para essas crianças. Isso sugere que a principal utilidade da CLP em menores de 4 anos, seria a monitorização da variação intraindividual, o que permitiria a avaliação da progressão da doença ou resposta a intervenções terapêuticas (ROCA et al, 2017).…”
Section: Discussionunclassified